Clinical trial
Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery
NCT00333918 is registered in ClinicalTrials.gov with Bausch & Lomb Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery
- Lead sponsor
- Bausch & Lomb Incorporated
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- March 31, 2007
- Enrollment
- 522 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.